American Century Companies’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $748M | Sell |
|
|||||
|
2025
Q2 | $585M | Buy |
|
|||||
|
2025
Q1 | $475M | Buy |
|
|||||
|
2024
Q4 | $377M | Buy |
|
|||||
|
2024
Q3 | $438M | Buy |
|
|||||
|
2024
Q2 | $329M | Sell |
|
|||||
|
2024
Q1 | $205M | Buy |
|
|||||
|
2023
Q4 | $79.4M | Sell |
|
|||||
|
2023
Q3 | $78.4M | Buy |
|
|||||
|
2023
Q2 | $83.4M | Sell |
|
|||||
|
2023
Q1 | $85.1M | Sell |
|
|||||
|
2022
Q4 | $166M | Buy |
|
|||||
|
2022
Q3 | $139M | Buy |
|
|||||
|
2022
Q2 | $83.9M | Sell |
|
|||||
|
2022
Q1 | $185M | Buy |
|
|||||
|
2021
Q4 | $170M | Sell |
|
|||||
|
2021
Q3 | $202M | Buy |
|
|||||
|
2021
Q2 | $177M | Sell |
|
|||||
|
2021
Q1 | $155M | Buy |
|
|||||
|
2020
Q4 | $140M | Buy |
|
|||||
|
2020
Q3 | $144M | Sell |
|
|||||
|
2020
Q2 | $148M | Buy |
|
|||||
|
2020
Q1 | $44.3M | Buy |
|
|||||
|
2019
Q4 | $31.7M | Sell |
|
|||||
|
2019
Q3 | $23.6M | Sell |
|
|||||
|
2019
Q2 | $24.1M | Sell |
|
|||||
|
2019
Q1 | $66.4M | Buy |
|
|||||
|
2018
Q4 | $50.5M | Buy |
|
|||||
|
2018
Q3 | $53.8M | Buy |
|
|||||
|
2018
Q2 | $42.1M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $730K | Sell |
|
|||||
|
2017
Q2 | $774K | Hold |
|
|||||
|
2017
Q1 | $497K | Hold |
|
|||||
|
2016
Q4 | $363K | Sell |
|
|||||
|
2016
Q3 | $690K | Sell |
|
|||||
|
2016
Q2 | $577K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $38.5M | Buy |
|
|||||
|
2015
Q1 | $26.8M | Buy |
|
|||||
|
2014
Q4 | $750K | Buy |
|
|||||
|
2014
Q3 | $586K | Hold |
|
|||||
|
2014
Q2 | $474K | Sell |
|
|||||
|
2014
Q1 | $3.37M | Sell |
|
|||||
|
2013
Q4 | $3.26M | Sell |
|
|||||
|
2013
Q3 | $3.25M | Buy |
|
|||||
|
2013
Q2 | $1.5M | Buy |
|